- Source type
- Study
- Access type
- Abstract/index
- Publisher
- JAMA
- Indexed by
- PubMed
- Date
- 2024
- Added
- 2026-06-19
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
This source is strongest for safety and clinical outcomes and weaker for consumer context and regulatory status.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 66/100
- Context Source
- Clinical outcomes
- 90/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 92/100
- Primary Anchor
- Consumer context
- 88/100
- Strong Support
- Trial discovery
- 89/100
- Strong Support
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
GLP-1s Are Not Just a Weight Loss Story
Roles: Primary source
Show section-level references
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity
Roles: Primary source
Show section-level references
Claim ledger
Claims supported
Reviewed claim cards that cite this source in the evidence graph.
glp 1: Cost, access, adherence, tolerability, and long-term maintenance materially affect
Cost, access, adherence, tolerability, and long-term maintenance materially affect the real-world value of GLP-1 therapy.
glp 1: Weight maintenance commonly depends on continued treatment, while optimal
Weight maintenance commonly depends on continued treatment, while optimal long-term strategies and lean-mass preservation remain active evidence gaps.
Related studies
Related sources
SURMOUNT-4 trial full text
PubMed Central used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed Central
- Access
- Full text
- Usage
- 3 connections
SURMOUNT-MMO trial registry: tirzepatide and morbidity/mortality in obesity
ClinicalTrials.gov / Lilly Trial Registry used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov / Lilly Trial Registry
- Access
- Publisher
- Usage
- 3 connections
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections